Opiate Analgesia: Evidence for Mediation by a Subpopulation of Opiate Receptors
暂无分享,去创建一个
[1] P. Cuatrecasas,et al. Multiple opiate receptors: different regional distribution in the brain and differential binding of opiates and opioid peptides. , 1979, Molecular pharmacology.
[2] D. L. Larson,et al. Chloroxymorphamine, and opioid receptor site-directed alkylating agent having narcotic agonist activity. , 1979, Science.
[3] P. Portoghese,et al. 6.beta.-[N,N-Bis(2-chloroethyl)amino]-17-(cyclopropylmethyl)-4,5.alpha.-epoxy-3,14-dihydroxymorphinan (chloranaltrexamine), a potent opioid receptor alkylating agent with ultralong narcotic antagonist activity , 1978 .
[4] John Hughes,et al. Endogenous opioid peptides: multiple agonists and receptors , 1977, Nature.
[5] J. Thompson,et al. The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. , 1976, The Journal of pharmacology and experimental therapeutics.
[6] S. Snyder,et al. Selective enhancement of [3H]opiate agonist binding by divalent cations. , 1975, Molecular pharmacology.
[7] S. Snyder,et al. Opiate receptor binding: Enzymatic treatments that discriminate between agonist and antagonist interactions , 1975 .
[8] S. Snyder,et al. Identification of novel high affinity opiate receptor binding in rat brain , 1975, Nature.
[9] S. Snyder,et al. Differentiation of opiate agonist and antagonist receptor binding by protein modifying reagents , 1975, Nature.
[10] S. Snyder,et al. Opiate receptor binding: effects of enzymatic treatments. , 1974, Molecular pharmacology.
[11] F. Wilcoxon,et al. A simplified method of evaluating dose-effect experiments. , 1948, The Journal of pharmacology and experimental therapeutics.
[12] Fred E. D'Amour,et al. A METHOD FOR DETERMINING LOSS OF PAIN SENSATION , 1941 .